Sun Pharma received US FDA acceptance of BLA for Tildrakizumab
Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.